FDA Approves Anjeso (meloxicam injection) for the Management of Moderate to Severe Pain

MALVERN, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news